PLoS Pathogens-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2023-10-25 南大来自江苏省

with editor已经两个周了，这个阶段一般要多久呀？

29 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2023-05-11 148a7117m39(暂无昵称) 来自广东省

With editor有13天了，咋回事呢？

65 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2021-09-13 ZYW MEDSCI

审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0
偏重的研究方向：天然免疫
经验分享：review很专业，真的非常非常专业，很认真的在审论文

120 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2021-08-05 zhenyuwang

二审审多久啊，6天了，没消息

151 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2020-02-19 146e8792m72暂无昵称

我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表:
10.27？我的也没动静

POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2021-12-29 衣谷

我的文章大概有几分？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

投nature需要什么准备？

103 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2021-03-02 Elife

To wnj1738555_28787312,

你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！

515 0

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2021-01-18 PNAS

病毒方面的文章，mBio上面文章的质量已经相当不错！

271 0

[GetPortalCommentsPageByObjectIdResponse(id=2164825, encodeId=64cc2164825f2, content=with editor已经两个周了，这个阶段一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Wed Oct 25 14:41:58 CST 2023, time=2023-10-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131539, encodeId=e6e621315391a, content=With editor有13天了，咋回事呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1045319862, createdName=148a7117m39(暂无昵称), createdTime=Thu May 11 09:08:22 CST 2023, time=2023-05-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1017069, encodeId=605b101e06976, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:2575.0 偏重的研究方向：天然免疫 经验分享：review很专业，真的非常非常专业，很认真的在审论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=ZYW MEDSCI, createdTime=Mon Sep 13 15:44:51 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005297, encodeId=ee03100529eba, content=二审审多久啊，6天了，没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967d4787650, createdName=zhenyuwang, createdTime=Thu Aug 05 09:49:42 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585005, encodeId=680558500554, content=我的1月中旬意见回来了，拒稿，补实验，重投。pp的套路，这样发表了显得审稿周期短POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, beContent=POIvictor 2020-01-08 00:00:00 发表: 10.27？我的也没动静, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc515176117, createdName=146e8792m72暂无昵称, createdTime=Wed Feb 19 00:00:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096741, encodeId=debe1096e41d2, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096742, encodeId=ac281096e4283, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944617, encodeId=331694461ec6, content=To wnj1738555_28787312, 你老针对个人评价干啥呢？评价一下期刊就行了，每个人都有自己的观点，更有发表自己观点的权利，何况我不又不是无中生有，我有自己的标准，你在这里表达出自己的观点就行了，也不用非要强迫别人同意你的观点啊！喜欢哪个期刊就投哪个期刊，投自己喜欢的期刊，可能其他朋友会认同我的观点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf551632376, createdName=Elife, createdTime=Tue Mar 02 00:13:33 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917823, encodeId=f57b91e823b5, content=病毒方面的文章，mBio上面文章的质量已经相当不错！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44001623014, createdName=PNAS, createdTime=Mon Jan 18 19:08:54 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909940, encodeId=658690994003, content=审稿速度:3.0 | 版面费用:2300.0 偏重的研究方向：医学;病毒 经验分享：mbio的质量距离plos pathogens还是有差距的 别听这个版上的无脑喷子的话 去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS mbio好像一篇都没有 这个Elife到处发帖子黑plos pathogens 是被拒了几次了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:40:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]

2020-12-22 wnj1738555_28787312

审稿速度:3.0 | 版面费用:2300.0
偏重的研究方向：医学;病毒
经验分享：mbio的质量距离plos pathogens还是有差距的
别听这个版上的无脑喷子的话
去看看每年微生物十大进展有多少发在plos pathogens 三分之一其他三分之二在NS PNAS
mbio好像一篇都没有
这个Elife到处发帖子黑plos pathogens 是被拒了几次了？

1 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务